Who Paid My Doc
Acp-101
Drug Hyperphagia In Prader-Willi Syndrome
General payments
$55,736
Research payments
$6,711,289
Through program year 2025, $55,736 in general payments and $6,711,289 in research payments were reported against Acp-101 (Hyperphagia In Prader-Willi Syndrome).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $47,261 | 28 |
| 2025 | Research | $4,394,229 | 302 |
| 2024 | General | $8,475 | 6 |
| 2024 | Research | $2,317,061 | 93 |
Breakdown
The top 5 of 16 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
34 general · 395 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.